×
The Standard e-Paper
Home To Bold Columnists
The Standard Group Plc is a
multi-media organization with investments in media platforms spanning newspaper
print operations, television, radio broadcasting, digital and online services. The
Standard Group is recognized as a leading multi-media house in Kenya with a key
influence in matters of national and international interest.
An experimental COVID-19 treatment pill called Molnupiravir being developed by Merck & Co Inc and Ridgeback Biotherapeutics LP, is seen in this undated handout photo released by Merck & Co Inc and obtained by Reuters May 17, 2021. [File/photo]
There is a silver lining in the fight against the coronavirus pandemic after an international pharmaceutical developed the first antiviral pill said to be effective against the virus.
Subscribe to our newsletter and stay updated on the latest developments and special offers!
join